Contact information
We are recruiting!
Expressions of interest are welcome from motivated and curious individuals at all career stages, including DPhil/PhD students, postdoctoral researchers and research assistants. Our work is highly interdisciplinary and collaborative, and we are committed to fostering a friendly, supportive and inclusive lab culture.
Research Assistant Position Open Now: Apply here
Prospective DPhil students can find more information about programmes here: https://www.kennedy.ox.ac.uk/study-with-us/study-with-us
If your background is in immunology/biomedical sciences, ophthalmology/rheumatology, computational biology or machine learning – or you are keen to develop expertise in these areas – we would be delighted to hear from you. Please email your CV and a short summary of your research interests to Dr Lakshanie C. Wickramasinghe (lakshanie.wickramasinghe@kennedy.ox.ac.uk).
Lakshanie C Wickramasinghe
BSc (Hons). PhD.
Kennedy Trust Transition Fellow of Rheumatology and St Cross Knoop Research Fellow in Ophthalmology
Ophthalmology • Rheumatology • Immunology • Stromal Mechanobiology • Translational Research
I am a Kennedy Trust Transition Fellow of Rheumatology and St Cross Knoop Research Fellow in Ophthalmology Fellow passionate about understanding how immune, stromal and mechanical cues shape inflammatory eye disease, with a particular focus on anterior uveitis.
My work centres on three complementary research strands: (1) investigating immune–stromal interactions in anterior uveitis within the Buckley–Coles Research Group and the Oxford–Janssen Eye Group (ORBIT consortium), working closely with Prof Christopher Buckley and Dr Kanmin Xue; (2) dissecting the cellular basis of inflammatory disease in uveitis in human patients with Dr Srilakshmi Sharma; and (3) understanding how mechanical cues within ocular tissues shape inflammation and tissue remodelling in collaboration with Dr Adrien Hallou and Prof Marco Fritzsche.
Using advanced imaging, bioinformatics, and molecular and cellular approaches, I aim to define the mechanisms that drive disease and identify targets that can be translated into new therapies. Across these programmes, my goal is to turn fundamental biological insight into therapeutic outcomes that preserve vision and improve quality of life for people living with inflammatory eye disease.